Condition

Parkinson Disease Dementia

ClinicalTrials.gov condition label

Clinical trials24
Recruiting5
Common interventions25
Lead sponsors shown15

Clinical trials

24 shown
Visual Hallucinations in Lewy Body DiseasesNCT07849413 · 2026-09-15
RECRUITING
Monoamine Oxidase B PET/CT in Various MAO-B-Related DiseaseNCT07685873 · 2026-06-25
RECRUITING
Elucidating the Role of Cholinergic Degeneration in Cognitive Fluctuations in Lewy Body DementiaNCT07284290 · 2025-12-08
RECRUITING
Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive ImpairmentsNCT07154511 · 2025-11-07
RECRUITING
Parkinson's Disease and Movement Disorders Clinical DatabaseNCT04997642 · 2019-09-30
RECRUITING
To Evaluate the Safety of DBS in Patients With Primary Parkinson's DiseaseNCT06494956 · 2024-07-01
UNKNOWN
PERSEVERE: Peer Mentor Support and Caregiver Education in Lewy Body DementiaNCT06389032 · 2024-05-13
ACTIVE_NOT_RECRUITING
SHARPEN - Parkinson's Disease DementiaNCT05987540 · 2024-05-08
TERMINATED
Family Caregiver Online Survey (Dementia and Swallowing Difficulties)NCT06471660 · 2023-11-07
COMPLETED
Environmental and Reproductive Health Risk for Lewy Body DementiaNCT06005935 · 2023-08-01
UNKNOWN
Brain Small Chain Fatty Acid Metabolism in Parkinson Disease: KetonesNCT05778695 · 2023-03-09
TERMINATED
A Study of Caregiver Connections Via Technology in DementiaNCT05779839 · 2023-02-22
ACTIVE_NOT_RECRUITING
Comparison Between Parkinson's Disease and Parkinson's Dementia Complex (Genetically,Clinical and Electrophysiological)NCT05759403 · 2022-11-01
UNKNOWN
A Study to Evaluate Caregiver Connections Via Technology for Patients With Alzheimer's and Other Types of DementiaNCT05497817 · 2022-09-01
WITHDRAWN
Community Outreach for Palliative Engagement -- Parkinson DiseaseNCT05222386 · 2022-04-26
ACTIVE_NOT_RECRUITING
ATH-1017 Treatment in Subjects With Parkinson's Disease Dementia or Dementia With Lewy Bodies (SHAPE Trial)NCT04831281 · 2022-01-20
TERMINATED
Sing for Your Saunter - Dementia SupplementNCT04518917 · 2021-04-19
COMPLETED
Dementias and Microbiota Composition: Is Possible to Revert the Dementia Symptoms Reverting the Microbiota Composition?NCT05943925 · 2021-04-16
UNKNOWN
The Efficacy of VESPA 2.0 for Cognitive Rehabilitation in Patients With Mild Cognitive ImpairmentNCT06281314 · 2021-03-01
COMPLETED
Learning to PERSEVERE: Peer Mentor Support and Caregiver Education in Lewy Body DementiaNCT04649164 · 2020-11-02
COMPLETED
OLE Study for Patients With Parkinson's Disease With Dementia Enrolled in Study ANAVEX2-73-PDD-001NCT04575259 · 2019-10-10
COMPLETED
Cholinergic Neurotransmission in Mobility and Cognition in Parkinson DiseaseNCT03840837 · 2019-05-02
COMPLETED
Innovations in Dementia Empowerment and ActionNCT03550131 · 2018-12-05
COMPLETED
Neuropsychological Assessment of Cognitive Decline in Patients With a Definite Parkinson's DiseaseNCT01113242 · 2010-06-01
COMPLETED

Common interventions

AlgorithmBEHAVIORAL2PlaceboDRUG2Random MatchBEHAVIORAL2ANAVEX2-73DRUG1Assessment of dynamic EEG features over 48-hour periods across all study aimsDIAGNOSTIC_TEST1ATH-1017DRUG1Behavioral TasksBEHAVIORAL1Caregiver EducationBEHAVIORAL1Cortical excitability using transcranial magnetic stimulationDIAGNOSTIC_TEST1Diagnostic Test: 18F-FPyCO/SMBT-1DIAGNOSTIC_TEST1Focus group to provide feedback on educational materials and mentoring programOTHER1Galantamine HBr extended-release 8mg capsules (8mg ER).DRUG1Implant devicePROCEDURE1Innovations in Dementia Empowerment and Action (IDEA)BEHAVIORAL1Ketone Ester (R)-3-Hydroxybutyl (R)-3-HydroxybutyrateDIETARY_SUPPLEMENT1Listening to musicBEHAVIORAL1Mentally SingingBEHAVIORAL1MRI/MEG ScansOTHER1Multi modal MRIDIAGNOSTIC_TEST1neuropsychiatric and cognitive testing questionnairesBEHAVIORAL1Neuropsychological AssessmentOTHER1No interventionOTHER1Non-invasive brainstem stimulationDEVICE1Online Community-Supported Palliative CareOTHER1Parkinson Disease Standard CareOTHER1

Trial status mix

COMPLETED8
RECRUITING5
UNKNOWN4
ACTIVE_NOT_RECRUITING3
TERMINATED3
WITHDRAWN1

Phase mix

NA11
PHASE23
PHASE42
PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.